(Q38200053)

30 August 2017

D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse (English)

1 reference

30 August 2017

1 reference

1

1 reference

30 August 2017

1 March 2014

1 reference

30 August 2017

Depression and Anxiety

1 reference

30 August 2017

31

1 reference

30 August 2017

3

1 reference

30 August 2017

175-177

1 reference

D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables

30 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

Augmentation of exposure therapy with post-session administration of D-cycloserine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

Enhancing exposure-based therapy from a translational research perspective

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

Reconsolidation and extinction of conditioned fear: inhibition and potentiation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006201

A high-throughput clinical assay for testing drug facilitation of exposure therapy

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FDA.22257

21 January 2018

Identifiers

DOI

10.1002/DA.22257

1 reference

30 August 2017

1 reference

PMC publication ID

4006201

30 August 2017

PubMed publication ID

24677604

1 reference

PMC publication ID

4006201